Svar på skriftligt spörsmål om att utvidga det nationella vaccinationsprogrammet 2021 med pneumokockvaccinationer för riskgrupper

This procedure involves a written response regarding the expansion of the 2021 national vaccination program. It specifically addresses the provision of pneumococcal vaccinations for high-risk groups to improve public health outcomes. The changes primarily affect individuals in designated medical risk groups and the healthcare providers responsible for administering the vaccines and managing public communication.